Literature DB >> 5879559

A comparative pharmacological study of a series of monohydroxylated and methoxylated chlorpromazine derivatives.

A A Manian, D H Efron, M E Goldberg.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1965        PMID: 5879559     DOI: 10.1016/0024-3205(65)90298-5

Source DB:  PubMed          Journal:  Life Sci        ISSN: 0024-3205            Impact factor:   5.037


× No keyword cloud information.
  7 in total

1.  Cerebrospinal fluid levels of chlorpromazine and it metabolites in schizophrenia.

Authors:  S Axelsson; S Jönsson; L Nordgren
Journal:  Arch Psychiatr Nervenkr (1970)       Date:  1975-12-31

2.  Chlorpromazine-induced hepatotoxicity during inflammation is mediated by TIRAP-dependent signaling pathway in mice.

Authors:  Adarsh Gandhi; Tao Guo; Pranav Shah; Bhagavatula Moorthy; Romi Ghose
Journal:  Toxicol Appl Pharmacol       Date:  2012-12-11       Impact factor: 4.219

3.  Radioimmunoassay for fluphenazine in human plasma.

Authors:  D H Wiles; M Franklin
Journal:  Br J Clin Pharmacol       Date:  1978-03       Impact factor: 4.335

4.  The relationship of plasma chlorpromazine to its 7-hydroxy and sulphoxide metabolites in a large population of chronic schizophrenics.

Authors:  A V Mackay; A F Healey; J Baker
Journal:  Br J Clin Pharmacol       Date:  1974-10       Impact factor: 4.335

5.  Single and repeated administration of neuroleptic drugs to rats: effects on striatal dopamine-sensitive adenylate cyclase and locomotor activity produced by tranylcypromine and L-tryptophan or L-Dopa.

Authors:  D J Heal; A R Green; D J Boullin; D G Grahame-Smith
Journal:  Psychopharmacology (Berl)       Date:  1976-09-29       Impact factor: 4.530

6.  Inhibition of 5-hydroxytryptamine-induced human blood platelet aggregation by chlorpromazine and its metabolites.

Authors:  D J Boullin; D G Grahame-Smith; R P Grimes; H F Woods
Journal:  Br J Pharmacol       Date:  1975-01       Impact factor: 8.739

Review 7.  Pharmacologically active drug metabolites: therapeutic and toxic activities, plasma and urine data in man, accumulation in renal failure.

Authors:  D E Drayer
Journal:  Clin Pharmacokinet       Date:  1976 Nov-Dec       Impact factor: 6.447

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.